Philip Dekes
Chief Financial Officer
Replay available
Lonza Group AG (LSE: 0QNO) Q1 2025 earnings conference call, held 2025-05-09. Replay captured from the company's public earnings webcast.

Chief Financial Officer
Analyst, JP Morgan
Analyst, RBC Europe
Analyst, Jefferies
Analyst, Goldman Sachs
Analyst, Stiefel
Analyst, Barclays
Analyst, UBS
Analyst, Bernstein
Ladies and gentlemen, welcome to the Lonza Q1 2025 Qualitative Update Conference Call and Live Webcast. I am Sandra, the Chorus Call Operator. I would like to remind you that all participants have been listened only mode and the conference has been recorded. The presentation will be followed by a Q&A session. You can register for questions at any time by pressing star and 1 on your telephone. Please limit yourself to one question and then re-enter the queue in case you have a follow-up. In the webcast, we have a chat box, which should only be used if your question cannot be heard over the phone line. For assistance, please press star and zero. The conference must not be recorded for publication or broadcast. At this time, it's my pleasure to hand over to Philip Dekes, CFO. Please go ahead, sir. Good morning, good afternoon, and a warm welcome to our Q1 2025 qualitative update. And thank you, Sandra, for the introduction. With our qualitative updates, we intend to provide you with a general business overview, but we will not be sharing figures related to our financial performance. We will do so on the 23rd of July with our half-year update. Let me start with an overview of our group performance, the current macroeconomic situation, and our growth projects before we move on to the divisional performance. We experienced a strong Q1 performance across our CDMO businesses aligned with our expected full-year trajectory. Supported by this strong performance, we are confirming our 2025 outlook for the CDMO business, with sales growth approaching 20% at constant exchange rates compared to the prior year and the core EBITDA margin approaching 30%. Including Vacaville, which is expected to contribute half a billion Swiss francs in sales at a dilutive core EBITDA margin, we expe...